Beijing Tiantan Biological Products Co., Ltd.

Shanghai Stock Exchange 600161.SS

Beijing Tiantan Biological Products Co., Ltd. Operating Cash Flow for the year ending December 31, 2023: USD 337.14 M

Beijing Tiantan Biological Products Co., Ltd. Operating Cash Flow is USD 337.14 M for the year ending December 31, 2023, a 106.62% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Beijing Tiantan Biological Products Co., Ltd. Operating Cash Flow for the year ending December 31, 2022 was USD 163.17 M, a 5.76% change year over year.
Beijing Tiantan Biological Products Co., Ltd. Operating Cash Flow for the year ending December 31, 2021 was USD 154.29 M, a 43.44% change year over year.
Beijing Tiantan Biological Products Co., Ltd. Operating Cash Flow for the year ending December 31, 2020 was USD 107.56 M, a 16.59% change year over year.
Beijing Tiantan Biological Products Co., Ltd. Operating Cash Flow for the year ending December 31, 2019 was USD 92.26 M, a -6.40% change year over year.

Key data

Date	Operating Cash Flow	Net Cash Used For Investing Activities	Net Cash Used Provided By Financing Activities	Dividends Paid

Shanghai Stock Exchange: 600161.SS

Beijing Tiantan Biological Products Co., Ltd.

CEO	Mr. Dao Xing Fu
IPO Date	June 16, 1998
Location	China
Headquarters	No. 2 Courtyard
Employees	4,858
Sector	Health Care
Industries Biotechnology Pharmaceuticals

Description

Beijing Tiantan Biological Products Co., Ltd. engages in the research and development, manufacture, sale, and consulting of blood products in China. Its products include blood intravenous injection immunoglobulin; blood human albumin; blood system intravenous injection; hepatitis B, freeze-dried hepatitis B, and tetanus human immunoglobulin; human immunoglobulin; and other blood products. The company was incorporated in 1998 and is headquartered in Beijing, China. Beijing Tiantan Biological Products Co., Ltd. operates as a subsidiary of China National Biotec Group Company Limited.

Key trends

Past 5 years